IP Library › Granted Patent US 9,839,511
Granted Patent B2
US 9,839,511 · App. 15/025,008 · Granted Dec 12, 2017

Device and method for mitral valve regurgitation treatment

Inventors: Jianlu Ma (Irvine, CA); Yong Huo (Beijing, CN); Tianzhu Li (Foothill Ranch, CA); Jinhong Zhao (Foothill Ranch, CA); Jianxiang Ma (Foothill Ranch, CA); Lei Meng (Foothill Ranch, CA)
Assignee: SINO MEDICAL SCIENCES TECHNOLOGY INC.
A61F2/24A61F2/2412A61F2/2418A61F2/2409A61F2210/0014A61F2220/005A61F2220/0008A61F2230/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,839,511
App. No.
15/025,008
Granted
Dec 12, 2017
Kind
B2
Abstract

A mitral valve replacement device is adapted to be deployed at a mitral valve position in a human heart. The device has an atrial flange defining an atrial end of the device, a ventricular portion defining a ventricular end of the device, the ventricular portion having a height ranging between 2 mm to 15 mm, and an annulus support that is positioned between the atrial flange and the ventricular portion. The annulus support includes a ring of anchors extending radially therefrom, with an annular clipping space defined between the atrial flange and the ring of anchors. A plurality of leaflet holders positioned at the atrial end of the atrial flange, and a plurality of valve leaflets secured to the leaflet holders, and positioned inside the atrial flange at a location above the native annulus.

Claims (33)

1. A mitral valve replacement device adapted to be deployed at a mitral valve position in a human heart, comprising:

an atrial flange defining an atrial end of the device, the atrial flange having a plurality of tabs, each tab extending radially outwardly to a bend, where the tab bends in a longitudinal direction toward the atrial end, and then extends radially inwardly to an end of the tab;

a ventricular portion defining a ventricular end of the device;

an annulus support that is positioned between the atrial flange and the ventricular portion, the annulus support including a ring of anchors extending radially therefrom, with an annular clipping space defined between the atrial flange and the ring of anchors;

a plurality of leaflet holders positioned at the atrial end of the atrial flange; and

a plurality of valve leaflets secured to the leaflet holders, and positioned inside the atrial flange at a location above the native annulus.

2. The device of claim 1 , further including at least one tail extending from the ventricular end of the ventricular portion.

3. The device of claim 1 , further including a neck positioned between the atrial flange and the annulus support.

4. The device of claim 3 , wherein each anchor extends radially from the neck and ends in a rounded tip that bends in a circumferential direction.

5. The device of claim 1 , wherein at least a portion of one or more of the atrial flange, the annulus support and ventricular portion is covered with tissue.

6. The device of claim 1 , wherein at least a portion of one or more of the atrial flange, the annulus support and ventricular portion is covered with fabric.

7. The device of claim 1 , wherein at least a portion of one or more of the atrial flange, the annulus support and portion is covered with tissue and fabric.

8. The device of claim 7 , wherein the tissue and fabric are comprised of a layer of combined tissue and fabric.

9. The device of claim 1 , wherein at least a portion of one or more of the atrial flange, the annulus support and ventricular portion is coated with a biocompatible adhesive.

10. The device of claim 1 , wherein the ventricular portion has a height ranging between 2 mm to 15 mm.

11. The device of claim 1 , wherein the plurality of tabs is arranged in an annular manner to form the atrial flange.

12. The device of claim 1 , wherein the ventricular portion comprises a plurality of V-shaped tabs.

13. A method of deploying a mitral valve replacement device at a native mitral valve position that includes a native mitral annulus and native mitral valve leaflets in a human heart, comprising:

providing a mitral valve replacement device comprising:

an atrial flange defining an atrial end of the device, the atrial flange having a plurality of tabs, each tab extending radially outwardly to a bend, where the tab bends in a longitudinal direction toward the atrial end, and then extends radially inwardly to an end of the tab;

a ventricular portion defining a ventricular end of the device;

an annulus support that is positioned between the atrial flange and the ventricular portion, the annulus support including a ring of anchors extending radially therefrom, with an annular clipping space defined between the atrial flange and the ring of anchors;

a plurality of leaflet holders positioned at the atrial end of the atrial flange; and

a plurality of valve leaflets secured to the leaflet holders, and positioned inside the atrial flange;

seating the atrial flange in the atrium above a native mitral valve annulus in a human heart in a manner where the plurality of leaflets are positioned above the native annulus; and

positioning the native mitral annulus and/or the native mitral valve leaflet(s) in the clipping space.

14. The method of claim 13 , wherein the mitral valve replacement device includes at least one tail extending from the ventricular end of the ventricular portion, the method further including:

attaching a wire or line to the at least one tail; and

manipulating the wire or line to adjust the position of the mitral valve replacement device at the native mitral valve position.

15. The method of claim 13 , further including providing the ventricular portion with a height ranging between 2 mm to 15 mm.

16. The method of claim 13 , further including arranging the plurality of tabs in an annular manner to form the atrial flange.

17. The method of claim 13 , wherein the ventricular portion comprises a plurality of V-shaped tabs.

18. The method of claim 13 , wherein the mitral valve replacement device further comprises a neck positioned between the atrial flange and the annulus support, and wherein each anchor extends radially from the neck and ends in a rounded tip that bends in a circumferential direction.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2024
From: SINOMED CARDIOVITA TECHNOLOGY INC.
To: SINO MEDICAL SCIENCES TECHNOLOGY INC.
Reel/Frame 067875/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2021
From: SINO MEDICAL SCIENCES TECHNOLOGY INC.
To: SINOMED CARDIOVITA TECHNOLOGY INC.
Reel/Frame 055501/0815 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2016
From: MA, JIANLU; HUO, YONG; LI, TIANZHU; ZHAO, JINHONG; MA, JIANXIANG; MENG, LEI
To: SINO MEDICAL SCIENCES TECHNOLOGY INC.
Reel/Frame 038102/0032 →
Continuity (5)
Continuation In Part 14279511 · May 16, 2014
Provisional Application 61927490 · Jan 15, 2014
Provisional Application 61887343 · Oct 5, 2013
Provisional Application 62024097 · Jul 14, 2014
Related Publication 20160235529A1 · Aug 18, 2016